HON
70
-3
GOOGL
54
-5
SYK
71
-2
BMY
63
2
ETR
65
-3
FLR
50
2
DE
39
3
DIS
68
6
GD
46
-13
MCK
73
-2
NOC
34
-6
DAL
88
-2
FAST
61
-3
SO
53
-4
BLK
72
2
FSLR
47
7
HUM
46
-2
TAP
60
-4
QCOM
57
2
CAH
54
-6
HON
70
-3
GOOGL
54
-5
SYK
71
-2
BMY
63
2
ETR
65
-3
FLR
50
2
DE
39
3
DIS
68
6
GD
46
-13
MCK
73
-2
NOC
34
-6
DAL
88
-2
FAST
61
-3
SO
53
-4
BLK
72
2
FSLR
47
7
HUM
46
-2
TAP
60
-4
QCOM
57
2
CAH
54
-6
Financhill
Back

Allogene Therapeutics Vs. ePlus Industry Stock Comparison

Sell
13

ALLO
Allogene Therapeutics

Last Price:
2.47
Seasonality Move:
-6.71%
Sell
29

PLUS
ePlus

Last Price:
80.50
Seasonality Move:
20.86%
Sell
13
Allogene Therapeutics (ALLO) is a Sell

Is Allogene Therapeutics a Buy, Sell or Hold?

  • The current Allogene Therapeutics [ALLO] share price is $2.46. The Score for ALLO is 13, which is 74% below its historic median score of 50, and infers higher risk than normal.
  • ALLO is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
29
ePlus (PLUS) is a Sell

Is ePlus a Buy, Sell or Hold?

  • The current ePlus [PLUS] share price is $80.48. The Score for PLUS is 29, which is 42% below its historic median score of 50, and infers higher risk than normal.
  • PLUS is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

ALLO Stock Price Chart

What is Allogene Therapeutics's stock price today?

  • The Allogene Therapeutics share price today is $2.46
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ALLO is experiencing selling pressure, which indicates risk of future bearish movement.

PLUS Stock Price Chart

What is ePlus's stock price today?

  • The ePlus share price today is $80.48
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and PLUS is experiencing slight selling pressure.

ALLO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.03 Buy
Relative Strength Index (14 RSI): 40.05 Sell
Chaikin Money Flow: -2615836 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (2.58 - 3) Sell
Bollinger Bands (100): (2.41 - 2.95) Sell

PLUS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -2.29 Sell
Relative Strength Index (14 RSI): 29.13 Sell
Chaikin Money Flow: -131262 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (89.57 - 100.91) Sell
Bollinger Bands (100): (81.36 - 98.26) Sell

ALLO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 2.95 Sell
20-day SMA: 2.81 Sell
50-day SMA: 2.75 Sell
200-day SMA: 3.17 Sell
8-day EMA: 2.81 Sell
20-day EMA: 2.82 Sell
50-day EMA: 2.76 Sell
200-day EMA: 3.08 Sell

PLUS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 92.25 Sell
20-day SMA: 94.05 Sell
50-day SMA: 95.08 Sell
200-day SMA: 83.6 Sell
8-day EMA: 89.64 Sell
20-day EMA: 92.96 Sell
50-day EMA: 93.52 Sell
200-day EMA: 84.4 Sell

Allogene Therapeutics Earnings Growth & ALLO Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.10 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.14 per share, and a decrease next year of $0.01 per share.

ePlus Earnings Growth & PLUS Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.11 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.53 per share, and a decrease next year of $0.07 per share.

Allogene Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

ePlus Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):